Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹1,01,165Cr
Rev Gr TTM
Revenue Growth TTM
25.33%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MARICO
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 3.7 | -3.2 | -0.8 | -1.9 | 1.7 | 6.7 | 7.6 | 15.4 | 19.8 | 23.3 | 30.7 | 26.6 |
| 1,847 | 1,903 | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,604 | 2,922 | 2,945 |
Operating Profit Operating ProfitCr |
| 17.5 | 23.2 | 20.1 | 21.2 | 19.4 | 23.7 | 19.6 | 19.1 | 16.8 | 20.1 | 16.1 | 16.7 |
Other Income Other IncomeCr | 68 | 46 | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 |
Interest Expense Interest ExpenseCr | 17 | 17 | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 |
Depreciation DepreciationCr | 43 | 36 | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 |
| 401 | 567 | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 |
| 96 | 131 | 116 | 109 | 79 | 131 | 119 | 112 | 96 | 143 | 118 | 107 |
|
Growth YoY PAT Growth YoY% | 18.7 | 15.7 | 17.3 | 15.9 | 4.9 | 8.7 | 20.3 | 5.2 | 7.8 | 8.2 | -0.2 | 13.3 |
| 13.6 | 17.6 | 14.5 | 15.9 | 14.1 | 17.9 | 16.3 | 14.5 | 12.6 | 15.7 | 12.4 | 13.0 |
| 2.3 | 3.3 | 2.7 | 3.0 | 2.5 | 3.6 | 3.3 | 3.1 | 2.6 | 3.9 | 3.2 | 3.5 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 5.0 | -1.6 | 6.8 | 16.0 | -0.3 | 10.0 | 18.2 | 2.6 | -1.1 | 12.2 | 20.1 |
| 4,863 | 4,966 | 4,759 | 5,185 | 6,008 | 5,846 | 6,457 | 7,831 | 7,954 | 7,627 | 8,692 | 10,743 |
Operating Profit Operating ProfitCr |
| 15.2 | 17.5 | 19.6 | 18.0 | 18.1 | 20.1 | 19.8 | 17.7 | 18.5 | 21.0 | 19.8 | 17.4 |
Other Income Other IncomeCr | 59 | 93 | 96 | 85 | 102 | 95 | 105 | 98 | 144 | 142 | 208 | 191 |
Interest Expense Interest ExpenseCr | 23 | 21 | 17 | 16 | 40 | 50 | 34 | 39 | 56 | 73 | 53 | 48 |
Depreciation DepreciationCr | 84 | 95 | 90 | 89 | 131 | 140 | 139 | 139 | 155 | 158 | 178 | 194 |
| 822 | 1,029 | 1,149 | 1,117 | 1,257 | 1,374 | 1,523 | 1,601 | 1,743 | 1,937 | 2,116 | 2,214 |
| 237 | 305 | 338 | 290 | 126 | 331 | 324 | 346 | 421 | 435 | 458 | 464 |
|
| | 23.7 | 12.1 | 2.0 | 36.8 | -7.8 | 15.0 | 4.7 | 5.3 | 13.6 | 10.4 | 5.5 |
| 10.2 | 12.0 | 13.7 | 13.1 | 15.4 | 14.3 | 14.9 | 13.2 | 13.5 | 15.6 | 15.3 | 13.4 |
| 4.5 | 5.5 | 6.2 | 6.3 | 8.6 | 7.9 | 9.1 | 9.5 | 10.1 | 11.5 | 12.6 | 13.2 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 65 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 129 | 130 |
| 1,760 | 1,957 | 2,257 | 2,456 | 2,873 | 2,921 | 3,151 | 3,219 | 3,670 | 3,703 | 3,845 | 3,922 |
Current Liabilities Current LiabilitiesCr | 1,102 | 1,314 | 1,249 | 1,458 | 1,724 | 1,753 | 2,013 | 2,153 | 2,429 | 2,444 | 2,461 | 2,837 |
Non Current Liabilities Non Current LiabilitiesCr | 190 | 36 | 45 | 68 | 198 | 181 | 239 | 228 | 561 | 808 | 1,611 | 1,636 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 1,828 | 2,107 | 2,390 | 2,794 | 3,200 | 3,149 | 3,336 | 3,505 | 3,820 | 4,003 | 5,083 | 5,393 |
Non Current Assets Non Current AssetsCr | 1,302 | 1,274 | 1,243 | 1,287 | 1,709 | 1,821 | 2,174 | 2,281 | 3,126 | 3,418 | 3,255 | 3,286 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 665 | 818 | 649 | 516 | 1,062 | 1,214 | 2,007 | 1,016 | 1,419 | 1,387 | 1,363 |
Investing Cash Flow Investing Cash FlowCr | -179 | -197 | -92 | 55 | -334 | -39 | -938 | 425 | -865 | 176 | -621 |
Financing Cash Flow Financing Cash FlowCr | -625 | -601 | -574 | -567 | -698 | -1,147 | -1,058 | -1,290 | -560 | -1,542 | -649 |
|
Free Cash Flow Free Cash FlowCr | 607 | 731 | 567 | 394 | 919 | 1,034 | 1,870 | 884 | 1,237 | 1,234 | 1,202 |
| 113.7 | 113.0 | 80.0 | 62.4 | 93.9 | 116.4 | 167.4 | 81.0 | 107.3 | 92.3 | 82.2 |
CFO To EBITDA CFO To EBITDA% | 76.4 | 77.8 | 56.0 | 45.4 | 80.1 | 82.6 | 126.2 | 60.4 | 78.4 | 68.5 | 63.7 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 24,964 | 31,287 | 37,985 | 42,095 | 44,567 | 35,484 | 53,139 | 65,111 | 62,029 | 64,304 | 84,395 |
Price To Earnings Price To Earnings | 44.6 | 48.5 | 51.2 | 51.7 | 40.0 | 34.8 | 45.3 | 53.0 | 47.5 | 43.3 | 51.6 |
Price To Sales Price To Sales | 4.3 | 5.2 | 6.4 | 6.1 | 5.6 | 4.4 | 6.0 | 6.2 | 5.6 | 5.8 | 6.7 |
Price To Book Price To Book | 13.7 | 15.5 | 15.9 | 16.3 | 14.8 | 11.6 | 16.2 | 19.4 | 16.3 | 16.7 | 21.1 |
| 28.8 | 29.6 | 32.8 | 37.1 | 33.5 | 24.2 | 33.1 | 38.7 | 34.2 | 31.5 | 39.4 |
Profitability Ratios Profitability Ratios |
| 45.6 | 49.0 | 52.3 | 47.0 | 45.2 | 48.9 | 46.9 | 42.9 | 45.2 | 50.8 | 50.3 |
| 15.2 | 17.5 | 19.6 | 18.0 | 18.1 | 20.1 | 19.8 | 17.7 | 18.5 | 21.0 | 19.8 |
| 10.2 | 12.0 | 13.7 | 13.1 | 15.4 | 14.3 | 14.9 | 13.2 | 13.5 | 15.6 | 15.3 |
| 39.1 | 46.9 | 44.4 | 39.1 | 38.7 | 42.1 | 41.1 | 42.9 | 40.8 | 46.1 | 47.9 |
| 32.0 | 34.7 | 34.0 | 32.0 | 37.7 | 34.2 | 36.5 | 37.5 | 34.8 | 39.2 | 41.7 |
| 18.7 | 21.4 | 22.3 | 20.3 | 23.0 | 21.0 | 21.8 | 21.7 | 19.0 | 20.2 | 19.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Executive Summary**
Marico Limited continues to demonstrate resilient performance, strategic agility, and successful diversification, with strong growth across core and emerging businesses. In FY25, the company surpassed **₹10,000 crores in consolidated revenue**, driven by disciplined execution, robust brand equity, and effective portfolio expansion. Market leadership in core categories—especially coconut oil—remains unchallenged, while strategic bets in **Foods, Premium Personal Care (PPC), and Digital-First Brands** are reshaping the growth trajectory.
Marico is evolving from a legacy FMCG player into a **profitable, digitally enabled consumer goods company**, balancing volume-led growth with premiumization and innovation. Key initiatives like **Project SETU, Sales 3.0**, and digital brand integration are driving distribution excellence, rural penetration, and urban channel expansion.
---
## **1. Market Leadership & Core Business Strength**
Marico maintains **dominant market shares** across key product categories in India:
- **63% in branded coconut oil** (Parachute remains category leader)
- **41% in oats**
- **29% in value-added hair oils (VAHO)**
- **47% in leave-in conditioners**
- **53% in male hair styling**
Despite raw material inflation pressures—particularly in **copra** due to weather and speculation—Parachute demonstrated **pricing inelasticity and volume resilience**, growing 5.5–6.5% historically during 35% price hikes. The recent **12% decline in copra prices** and improved monsoon outlook are expected to support **volume recovery**, especially as smaller players retreat.
---
## **2. Strategic Diversification: New Growth Engines**
Marico’s growth strategy is anchored on the **“4 Ds”**: **Diversification, Distribution, Digital, and Diversity**. The shift in domestic revenue mix reflects aggressive success in scaling newer businesses.
### **a. Foods Business**
- Reached **₹900+ crores in FY25**, growing at a **33% YoY rate** (5x growth since FY20).
- Key drivers: **Saffola Oats, Muesli, Honey, Soya Chunks, Plix, True Elements**.
- Innovation focus:
- _Saffola Masala Millets_, _Cuppa Oats_, _Munchiez (low-fat snacking)_.
- Expansion into health snacking, plant-based protein, and breakfast cereals.
- **Distribution expansion** into general trade (GT), chemists, and modern trade via Project SETU.
- **Targets**:
- **~8x FY20 revenue by FY27 (~₹1,800 crores)**.
- **>25% CAGR** through innovation, GT penetration, and omnichannel sales.
### **b. Premium Personal Care (PPC)**
- Grew at a **24% CAGR (FY21–FY25)**; PPPC revenue share in international business up from **20% to 29% (FY25)**.
- Key focus: **shampoos, serums, skincare, baby care, male grooming**.
- India PPC driven by **Livon (serums), Set Wet (EDPs), Puresense, and Herbs India** (MENA).
- **International premiumization ongoing** in Bangladesh, Vietnam, and MENA.
- **Targets**:
- Sustain **25%+ CAGR**.
- Maintain **double-digit constant currency growth** in international markets despite macro volatility.
### **c. Digital-First Brands**
- Achieved **₹750 crores APR (Annualised Recurring Revenue, FY25)**.
- Portfolio includes:
- **Beardo** (male grooming – now **66% non-beard revenue**, near **double-digit EBITDA**).
- **Plix** (nutraceuticals – reached **breakeven**, single-digit EBITDA).
- **Just Herbs & True Elements** (near breakeven, targeting 20–25% growth).
- **Integrated profit model**: Leveraging **Marico’s manufacturing, procurement, and media buying** for margin uplifts (e.g., **500–600 bps gross margin improvement for Beardo** via insourcing).
- **Targets**:
- Scale to **~2.5x FY24 APR by FY27 (~₹1,000–1,100 crores)**.
- Achieve **blended double-digit EBITDA margin** by FY27.
- **₹100 crore revenue opportunity** from **Kaya collaboration** (dermatologist-backed products).
---
## **3. Distribution & Sales Transformation**
### **Project SETU (Sales Expansion through Urban & Rural Reach)**
- Launched in **April 2024**, expanded to **11 states**.
- Aims to increase **direct distribution from 1M to 1.5M outlets by FY27**.
- Cost-neutral, funded via **trade spend optimization** and efficiency gains.
- Focus: **Rural GT expansion, specialty channels (chemists, bakeries), product assortment in urban outlets**.
- Early results show improved **distributor ROI, GT channel recovery, and penetration of secondary brands**.
### **Sales 3.0 Framework**
- Restructured sales from **4 divisions to 7 consumer-behavior-driven clusters**.
- Enhances **micro-market decision-making**, powered by:
- **Sales Control Tower**.
- **EDGE (Every Day Great Execution)**.
- **AI-powered product recommendation engine** (piloted).
- Supports **focused strategies across GT, modern trade, e-commerce, and quick commerce**.
### **Quick Commerce & Omnichannel**
- **Quick commerce contributes ~3%** of India business.
- Brands like **Saffola Oats, Plix, Beardo, PureSense** are adapting packs for impulse purchase.
- **ConCore platform (AI-powered consumer engagement tool)** launched with Salesforce to enhance support and personalization.
---
## **4. International Business: Geographic Diversification & Premiumization**
- **~26% of group revenue**.
- Reduced reliance on Bangladesh (from **51% in FY22 to ~42% in FY25**) via growth in **MENA, South Africa, and Vietnam**.
- **Double-digit constant currency growth in FY25**, despite challenges.
- Key growth drivers:
- Bangladesh: expansion into **shampoos, baby care, skincare** (non-coconut oil now ~60% of business).
- Vietnam: **female personal care (Lashe, Purity, Oliv), seasoning (Thuan Phat)**.
- South Africa: **Isoplus (XTREME styling), healthcare products**.
- MENA: **Herbs India, Parachute variants, Purité de Prôvence**.
- Strategy: Replicate Bangladesh’s **distribution-led model**, invest in premiumization, and pursue **inorganic opportunities**.
---
## **5. Portfolio Optimization & Brand Strategy**
- **SKU Rationalization** across brands to focus on **fewer, higher-potential products**.
- **Shift away from low-margin segments** like Amla hair oils in favor of **higher-margin, mid-premium brands** (e.g., Parachute Advansed, Hair & Care).
- **Avoided price wars**, instead focusing on **brand equity and share of voice**.
- **Double-digit volume growth** reported in non-core VAHO brands like **Jasmine, Aloe, Ayurvedic, and Hair & Care**.
---
## **6. Innovation & R&D**
- Operates **state-of-the-art Mumbai R&D center** with **134 experts** (108 in India).
- Focus areas: **Hair biology, dermatology, functional nutrition, Ayurvedic science**.
- Launched **over 15 new products in FY25**, including:
- **Parachute Advansed variants** with keratin, biotin, vitamin E, aloe vera, and baby care range.
- **Saffola Cold-Pressed Oils, Masala Millets, Muesli, Peanut Butter, Mayonnaise**.
- **Plix digital-first campaigns (Build Your Own Box, #PlixWeightLossQuiz)**.
- Collaborations with **Kaya Limited** to scale **efficacy-driven dermatology products** outside clinics.
---
### **Key Risks & Mitigation**
- **Input Cost Volatility (e.g., copra)**: Countered through **pricing, inventory management, and cost efficiency**.
- **Rural Demand Fluctuations**: Monitored via **Project SETU, rural investment**, and festive season momentum.
- **International Macroeconomic Pressure**: Diversification, **pricing, and cost optimization** in key markets.
- **Digital Competition**: Avoided cash burn model; focused on **profitable scalability via synergies**.